Published in Cephalalgia on February 01, 2002
Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology (2009) 2.40
Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci (2011) 1.71
The TRPA1 channel in migraine mechanism and treatment. Br J Pharmacol (2014) 1.50
Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. CNS Drugs (2010) 1.48
Photophobia in primary headaches. Headache (2015) 1.45
Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc Natl Acad Sci U S A (2005) 1.33
Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. Nucleic Acids Res (2003) 1.32
Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine. J Neurosci (2009) 1.30
Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res (2008) 1.20
Mechanisms involved in the cerebrovascular dilator effects of cortical spreading depression. Prog Neurobiol (2008) 1.18
IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One (2011) 1.13
Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. Expert Rev Mol Med (2011) 1.13
Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol (2007) 1.09
Migraine: where and how does the pain originate? Exp Brain Res (2009) 1.06
Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP. Neuropharmacology (2009) 1.04
New drugs for migraine. J Headache Pain (2009) 1.02
Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice. J Pain (2009) 1.02
Calcitonin gene-related peptide: an update on the biology. Curr Opin Neurol (2009) 1.01
Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol (2014) 1.00
Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine. Headache (2008) 0.99
Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist. J Neurosci (2012) 0.98
Stress and sleep duration predict headache severity in chronic headache sufferers. Pain (2012) 0.96
Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev (2014) 0.96
Migraine pain: reflections against vasodilatation. J Headache Pain (2009) 0.94
Activation characteristics of transient receptor potential ankyrin 1 and its role in nociception. Am J Physiol Cell Physiol (2011) 0.93
Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. Br J Pharmacol (2004) 0.92
CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. Br J Pharmacol (2008) 0.90
CGRP and migraine: could PACAP play a role too? Neuropeptides (2013) 0.90
Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine. Br J Pharmacol (2012) 0.89
Targeting TRP channels for novel migraine therapeutics. ACS Chem Neurosci (2014) 0.87
Spontaneous trigeminal allodynia in rats: a model of primary headache. Headache (2012) 0.87
Modelling headache and migraine and its pharmacological manipulation. Br J Pharmacol (2014) 0.86
Therapeutic antibodies against CGRP or its receptor. Br J Clin Pharmacol (2015) 0.86
Migraine is a neuronal disease. J Neural Transm (Vienna) (2010) 0.86
Cyclic AMP Accumulation in Migraine Induction. Pediatr Neurol Briefs (2015) 0.86
Calcitonin gene-related peptide: A molecular link between obesity and migraine? Drug News Perspect (2010) 0.85
Antidromic vasodilatation and the migraine mechanism. J Headache Pain (2011) 0.85
Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain (2008) 0.85
Direct interactions between calcitonin-like receptor (CLR) and CGRP-receptor component protein (RCP) regulate CGRP receptor signaling. Endocrinology (2012) 0.85
Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment. J Headache Pain (2013) 0.84
A Potential Preclinical Migraine Model: CGRP-Sensitized Mice. Mol Cell Pharmacol (2009) 0.83
Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period. J Headache Pain (2009) 0.83
New strategies for the treatment and prevention of primary headache disorders. Nat Rev Neurol (2016) 0.83
Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway. Br J Pharmacol (2015) 0.83
The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion. J Headache Pain (2013) 0.81
Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev (2017) 0.81
Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP. J Headache Pain (2010) 0.81
Calcitonin gene-related peptide receptor antagonists: beyond migraine pain--a possible analgesic strategy for osteoarthritis? Curr Pain Headache Rep (2013) 0.81
Two TRPV1 receptor antagonists are effective in two different experimental models of migraine. J Headache Pain (2015) 0.81
DNA methylation of RAMP1 gene in migraine: an exploratory analysis. J Headache Pain (2015) 0.81
Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine. J Mol Neurosci (2012) 0.81
How does rhinovirus cause the common cold cough? BMJ Open Respir Res (2016) 0.80
Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment. J Headache Pain (2009) 0.80
Neurovascular contributions to migraine: Moving beyond vasodilation. Neuroscience (2016) 0.80
Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres. Neuropharmacology (2012) 0.80
New directions in migraine. BMC Med (2011) 0.80
Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model. Br J Clin Pharmacol (2015) 0.79
The PACAP receptor: a novel target for migraine treatment. Neurotherapeutics (2010) 0.79
Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia. Cephalalgia (2011) 0.79
Role of CGRP-receptor component protein (RCP) in CLR/RAMP function. Curr Protein Pept Sci (2013) 0.79
Topiramate inhibits trigeminovascular activation: an intravital microscopy study. Br J Pharmacol (2005) 0.78
Effects of heating coagulation of middle meningeal artery on plasma CGRP level and c-fos expression in migraine rat triggered by nitroglycerin. Neurol Sci (2011) 0.78
Trigeminal TRPs and the scent of pain. Pain (2010) 0.78
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points. Neurology (2016) 0.78
A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation. Br J Pharmacol (2015) 0.78
Repression of calcitonin gene-related peptide expression in trigeminal neurons by a Theobroma cacao extract. J Ethnopharmacol (2007) 0.78
Analysis of the proteolysis of bioactive peptides using a peptidomics approach. Nat Protoc (2013) 0.78
Calcitonin Gene-Related Peptide Modulates Heat Nociception in the Human Brain - An fMRI Study in Healthy Volunteers. PLoS One (2016) 0.78
Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms. Neuropsychiatr Dis Treat (2015) 0.77
Effect of CGRP and sumatriptan on the BOLD response in visual cortex. J Headache Pain (2012) 0.77
Molecular investigations of BK(Ca) channels and the modulatory beta-subunits in porcine basilar and middle cerebral arteries. J Mol Histol (2009) 0.77
CGRP receptor antagonists: A new frontier of anti-migraine medications. Drug Discov Today Ther Strateg (2006) 0.76
Endosomal proteolysis regulates calcitonin gene-related peptide responses in mesenteric arteries. Br J Pharmacol (2012) 0.76
RNA Sequencing of Trigeminal Ganglia in Rattus Norvegicus after Glyceryl Trinitrate Infusion with Relevance to Migraine. PLoS One (2016) 0.76
K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries. Br J Pharmacol (2008) 0.76
Evidence for CGRP re-uptake in rat dura mater encephali. Br J Pharmacol (2010) 0.76
Quinoline derivatives: candidate drugs for a class B G-protein coupled receptor, the calcitonin gene-related peptide receptor, a cause of migraines. CNS Neurol Disord Drug Targets (2014) 0.75
Calcitonin gene-related peptide and pain: a systematic review. J Headache Pain (2017) 0.75
The link between obesity and migraine in childhood: a systematic review. Ital J Pediatr (2017) 0.75
Verisimilitude (or "truthlikeness") as an alternative to pro and cons: migraine and cluster headache mechanisms. J Headache Pain (2010) 0.75
Impact of Food Components on in vitro Calcitonin Gene-Related Peptide Secretion-A Potential Mechanism for Dietary Influence on Migraine. Nutrients (2016) 0.75
The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain (2017) 0.75
Gastrointestinal Headache; a Narrative Review. Emerg (Tehran) (2016) 0.75
Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis. Neural Regen Res (2013) 0.75
Characterization of a mouse model of headache. Pain (2016) 0.75
From blast to bench: A translational mini-review of posttraumatic headache. J Neurosci Res (2017) 0.75
ACS chemical neuroscience molecule spotlight on Telcagepant (MK-0974). ACS Chem Neurosci (2011) 0.75
Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms. J Neurosci (2017) 0.75
Effects of Voluntary Locomotion and Calcitonin Gene-Related Peptide on the Dynamics of Single Dural Vessels in Awake Mice. J Neurosci (2016) 0.75
The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis. J Headache Pain (2017) 0.75
Prophylactic Treatment of Migraine. Noro Psikiyatr Ars (2013) 0.75
Update in new medications for primary care. J Gen Intern Med (2009) 0.75
Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management. Neuroradiol J (2013) 0.75
CGRP as a neuropeptide in migraine: lessons from mice. Br J Clin Pharmacol (2015) 0.75
Role of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5A. PLoS One (2014) 0.75
The role of anti-CGRP antibodies in the pathophysiology of primary headaches. Neurol Sci (2017) 0.75
Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat. J Neural Transm (Vienna) (2015) 0.75
Lack of migraine in headaches of familial dysautonomia patients. J Neural Transm (Vienna) (2012) 0.75
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Understanding the biologic basis of migraine. N Engl J Med (1994) 5.25
Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol (1991) 4.78
Autoregulation of brain circulation in severe arterial hypertension. Br Med J (1973) 4.11
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell (1988) 2.84
Questionnaire versus clinical interview in the diagnosis of headache. Headache (1991) 2.36
Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia (1992) 2.33
Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol (1988) 2.30
Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia (1996) 2.29
Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe. Stroke (1974) 2.26
Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology (2011) 2.24
Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health (1992) 2.12
Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet (1991) 2.11
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology (2000) 2.10
Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol (1981) 2.03
Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia (2006) 2.01
Phosphorylation regulates in vivo interaction and molecular targeting of serine/arginine-rich pre-mRNA splicing factors. J Cell Biol (1999) 2.00
Symptomatic and nonsymptomatic headaches in a general population. Neurology (1992) 1.99
The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain (2006) 1.97
Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol (1995) 1.96
Increased familial risk and evidence of genetic factor in migraine. BMJ (1995) 1.96
A nosographic analysis of the migraine aura in a general population. Brain (1996) 1.91
Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol (1990) 1.87
Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia (1995) 1.82
Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81
Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia (1994) 1.68
Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology (2010) 1.66
Pressure-controlled palpation: a new technique which increases the reliability of manual palpation. Cephalalgia (1995) 1.64
Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia (1996) 1.62
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS. Neurology (1998) 1.62
Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports (2001) 1.60
Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology (1994) 1.59
Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum (1997) 1.58
Presentation of a new instrument: the diagnostic headache diary. Cephalalgia (1992) 1.57
Muscle palpation with controlled finger pressure: new equipment for the study of tender myofascial tissues. Pain (1994) 1.54
Interrelations between migraine and tension-type headache in the general population. Arch Neurol (1992) 1.53
Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet (1999) 1.52
Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur J Neurol (2003) 1.49
Diagnosis and management of migraine. BMJ (1996) 1.47
Botulinum toxin in headache treatment: the end of the road? Cephalalgia (2006) 1.46
The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology (1972) 1.46
Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia (2010) 1.45
Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide. Cephalalgia (1994) 1.44
Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain (1999) 1.43
Cerebral lactate production and blood flow in acute stroke. J Magn Reson Imaging (1992) 1.42
Determination of the luminal diameter of the radial artery in man by high frequency ultrasound: a methodological study. Ultrasound Med Biol (1990) 1.41
Ischemic stroke and incomplete infarction. Stroke (1996) 1.41
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia (2005) 1.39
The International classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry (2004) 1.39
Exteroceptive suppression of temporal muscle activity is normal in chronic tension-type headache and not related to actual headache state. Cephalalgia (1996) 1.39
Evaluation of pericranial myofascial nociception by pressure algometry. Reproducibility and factors of variation. Cephalalgia (1992) 1.39
Myofibre damage in human skeletal muscle: effects of electrical stimulation versus voluntary contraction. J Physiol (2007) 1.38
Pressure-sensitive devices. Pain (1995) 1.38
[Sumatriptan (Imigran) to patients with hemiplegic migraine?]. Ugeskr Laeger (1992) 1.38
[Are psychiatric diseases brain diseases?]. Ugeskr Laeger (1999) 1.38
[Decreased pain threshold and tolerance in patients with chronic tension headache]. Ugeskr Laeger (1997) 1.38
Resource allocation to brain research in Europe (RABRE). Eur J Neurosci (2006) 1.34
A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain (2002) 1.34
Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol (1999) 1.33
Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain (1989) 1.31
A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry (1996) 1.27
Quantitative evaluation of normal and pathologic cerebral blood flow regulation to perfusion pressure. Changes in man. Arch Neurol (1973) 1.25
Sporadic hemiplegic migraine. Cephalalgia (2004) 1.25
Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med (1989) 1.23
Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport (1993) 1.22
Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain (1984) 1.20
The effects of PaCO2 on regional cerebral blood flow and internal carotid arterial pressure during carotid clamping. Anesthesiology (1971) 1.18
The relative role of genetic and environmental factors in migraine without aura. Neurology (1999) 1.17
Inheritance of migraine investigated by complex segregation analysis. Hum Genet (1995) 1.16
Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia (2005) 1.16
Screening for migraine in the general population: validation of a simple questionnaire. Cephalalgia (1998) 1.16
Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia (1999) 1.15
Leao's spreading depression in the hippocampus explains transient global amnesia. A hypothesis. Acta Neurol Scand (1986) 1.15
Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer. Pain (1986) 1.13
Contralateral focal increase of cerebral blood flow in man during arm work. Brain (1971) 1.13
Analgesic headache. BMJ (1995) 1.13
The Copenhagen Acute Headache Clinic: organization, patient material and treatment results. Headache (1979) 1.12
Pericranial tenderness in tension headache. A blind, controlled study. Cephalalgia (1987) 1.11
Migraine without aura and migraine with aura are inherited disorders. Cephalalgia (1996) 1.11
A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol (1994) 1.10
Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain (2000) 1.09
Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology (1994) 1.09
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia (2008) 1.09
Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache (1978) 1.09
Classification of primary headaches. Neurology (2004) 1.08
In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med (1988) 1.08
Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine. Stroke (1994) 1.08
Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia (1992) 1.07
Migraine without aura: a population-based twin study. Ann Neurol (1999) 1.06